Lawyer profile
Greg Van Buiten
Latham & Watkins LLP
- Firm
- Latham & Watkins LLP
- Practice
- capital markets, Capital Markets, corporate
- Office
- Not stated
- Active in the record
- 2023 to 2026
Deal experience
Deals
5 announced deals in the record Latham & Watkins Advises on Vir Biotechnology’s US$150 Million Public Offering of Common Stock 16 Nov 2026
Latham Advises on Scribe Therapeutics’ US$155.51 Million IPO 28 Jul 2026
Latham & Watkins Advises on Allogene Therapeutics’ US$200.4 Million Public Offering of Common Stock 20 Apr 2026
Latham & Watkins Advises on BridgeBio’s US$500 Million Convertible Senior Notes Offering 27 Feb 2025
Free account
1 more recent deals
Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.
Deal alerts PRO
Get an email when Greg Van Buiten is named on a newly announced deal.
Alerts come as one daily email at most.
Free account
Register free to unlock
- Every lawyer on every deal team, not just the first three
- The full recent-deal list on lawyer pages
- Claim and edit your own firm or lawyer profile
- Submit deals and corrections
- Request a Pro trial for your team
You have a free account. Everything in this column is open to you.
Pro
Get Pro for the full picture on Greg Van Buiten
- Complete deal history with keyword, type, sector and year filters
- Frequent co-counsel and the firms most often on the other side
- Repeat clients, as named in the announcements
- Market share and deals by year, sector and deal type
- Deal alerts by firm, lawyer, sector, deal type or jurisdiction
- CSV and Excel export, up to 1,000 rows a day, and custom reports
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile